Literature DB >> 12672739

Hydroxyurea and sickle cell disease: a chance for every patient.

Debra L Weiner, Carlo Brugnara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12672739     DOI： 10.1001/jama.289.13.1692

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease.

Authors:  Maria L Jison; Peter J Munson; Jennifer J Barb; Anthony F Suffredini; Shefali Talwar; Carolea Logun; Nalini Raghavachari; John H Beigel; James H Shelhamer; Robert L Danner; Mark T Gladwin
Journal:  Blood       Date:  2004-03-18       Impact factor: 22.113

2.  Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Prodrugs as Drug Candidates for the Treatment of Ischemic Disorders: Insights into NO-Releasing Prodrug Biotransformation and Hemoglobin-NO Biochemistry.

Authors:  Guoyan G Xu; Tanvi M Deshpande; Mohini S Ghatge; Akul Y Mehta; Abdel Sattar M Omar; Mostafa H Ahmed; Jurgen Venitz; Osheiza Abdulmalik; Yan Zhang; Martin K Safo
Journal:  Biochemistry       Date:  2015-12-03       Impact factor: 3.162

Review 3.  Sickle cell disease: new opportunities and challenges in Africa.

Authors:  J Makani; S F Ofori-Acquah; O Nnodu; A Wonkam; K Ohene-Frempong
Journal:  ScientificWorldJournal       Date:  2013-09-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.